The adverse effects of DES became evident in the 1970s when the daughters of women who took DES during pregnancy were found to have a higher incidence of a rare vaginal cancer known as clear cell adenocarcinoma. There was also an increased risk of reproductive abnormalities in both male and female offspring, including infertility and structural changes in reproductive organs.
